Is Macrobid (nitrofurantoin) effective for treating nitrate-positive urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, Macrobid (nitrofurantoin) is effective for treating nitrate-positive urinary tract infections (UTIs). The standard dosage for acute uncomplicated UTIs is typically Macrobid 100 mg taken twice daily with food for 5 days, as recommended by the American College of Physicians 1. For complicated or recurrent UTIs, treatment may be extended to 7-14 days. Nitrofurantoin works by damaging bacterial DNA and inhibiting protein synthesis, making it effective against many common UTI-causing bacteria, including most strains of E. coli. The presence of nitrates in urine indicates bacterial activity, as certain bacteria convert nitrates to nitrites, which is what the dipstick test detects. Macrobid achieves high concentrations in urine while maintaining low serum levels, making it ideal for urinary tract infections.

Some key points to consider when prescribing Macrobid include:

  • Taking the full course of antibiotics even if symptoms improve
  • Taking Macrobid with food to increase absorption and reduce stomach upset
  • Drinking plenty of water during treatment
  • Avoiding Macrobid in patients with significant kidney impairment (creatinine clearance <30 mL/min), during late pregnancy, and in those with G6PD deficiency, as noted in various studies 1.

It's also important to note that the IDSA/European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guideline recommends treatment durations depending on the type of antibiotic, including 5 days of nitrofurantoin, 3 days of TMP–SMX, or a single dose of fosfomycin 1. However, the most recent and highest quality study 1 supports the use of Macrobid for 5 days as an effective treatment for uncomplicated UTIs.

From the Research

Effectiveness of Macrobid for Nitrate-Positive UTIs

  • Macrobid (nitrofurantoin) is effective against Escherichia coli and other pathogens that cause uncomplicated urinary tract infections (UTIs) 2, 3, 4.
  • Studies have shown that nitrofurantoin has good efficacy and tolerability in short-term therapy, comparable to other standard therapeutic regimens 2, 5.
  • Nitrofurantoin is recommended as a first-line antibiotic for empiric antibacterial treatment of uncomplicated cystitis in otherwise healthy women 2, 3.

Considerations for Nitrate-Positive UTIs

  • Nitrofurantoin is effective against nitrate-positive UTIs, but its effectiveness may be limited in cases of renal insufficiency 6.
  • The risk of treatment failure with nitrofurantoin is lower compared to other antibiotics, such as trimethoprim-sulfamethoxazole (TMP/SMX) 5.
  • Nitrofurantoin is a good option for treating UTIs caused by multi-drug resistant pathogens 4.

Important Notes

  • Nitrofurantoin is contraindicated in the last three months of pregnancy and in patients with renal impairment of any degree 2.
  • Long-term use of nitrofurantoin can lead to serious side effects, such as pulmonary reactions and polyneuropathy 2, 3.
  • Nitrofurantoin should be used with caution in patients with renal insufficiency, and its effectiveness may be limited in cases of severe renal impairment 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].

Medizinische Monatsschrift fur Pharmazeuten, 2014

Research

Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.